Expression of adrenomedullin and its receptor by chondrocyte phenotype cells

Biochemical and Biophysical Research Communications

Volumn 303, Issue 1, 2003, Pages 379-386

  Chosa, Etsuo ^a   Hamada, Hiroaki ^a   Kitamura, Kazuo ^a   Kuwasako, Kenji ^a   Yanagita, Toshihiko ^a   Eto, Tanenao ^a   Tajima, Naoya ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; cAMP; Chondrocyte phenotype; Receptor

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; FORSKOLIN; ISOQUINOLINE DERIVATIVE; MEMBRANE PROTEIN; PEPTIDE; RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN; SIGNAL PEPTIDE; SULFONAMIDE;

ARTICLE; CARTILAGE CELL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; RADIOIMMUNOASSAY; TIME;

ADRENOMEDULLIN; BUCLADESINE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FORSKOLIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOQUINOLINES; MEMBRANE PROTEINS; PEPTIDES; PHENOTYPE; RADIOIMMUNOASSAY; RECEPTORS, PEPTIDE; SULFONAMIDES; TIME FACTORS;

EID: 0037470826     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00347-4     Document Type: Article

References (40)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
2. Kano H., Kohno M., Yasunari K., Yokokawa K., Horio T., Ikeda M., Minami M., Hanehira T., Takeda T., Yoshikawa J. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J. Hypertens. 14:1996;209-213.
3. Ishizaka Y., Tanaka M., Kitamura K., Kangawa K., Minamino N., Matsuo H., Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 200:1994;642-646.
4. Cornish J., Callon K.E., Coy D.H., Jiang N.Y., Xiao L., Cooper G.J., Reid I.R. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am. J. Physiol. 273:1997;1113-1120.
5. Cornish J., Callon K.E., Bava U., Coy D.H., Mulvey T.B., Murray M.A., Cooper G.J., Reid I.R. Systemic administration of adrenomedullin (27-52) increases bone volume and strength in male mice. Endocrinology. 170:2001;251-257.
6. Naot D., Callon K.E., Grey A., Cooper G.J., Reid I.R., Cornish J. A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology. 142:2001;1849-1857.
7. Asada Y., Hara S., Marutsuka K., Kitamura K., Tsuji T., Sakata J., Sato Y., Kisanuki A., Eto T., Sumiyoshi A. Novel distribution of adrenomedullin-immunoreactive cells in human tissues. Histochem. Cell Biol. 112:1999;185-191.
8. Benya P.D., Padilla S.R., Nimni M.E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell. 15:1978;1313-1321.
9. Benya P.D., Nimni M.E. The stability of the collagen phenotype during stimulated collagen, glycosaminoglycan and DNA synthesis by articular cartilage organ cultures. Arch. Biochem. Biophys. 192:1979;327-335.
10. Benya P.D., Shaffer J.D. De-differentiated chondrocytes re-express the differentiated collagen phenotype when cultured in agarose gels. Cell. 30:1982;373-384.
11. Aulthouse A.L., Beck M., Griffey E., Sanford J., Arden K., Machado M.A., Horton W.A. Expression of the human chondrocyte phenotype in vitro. In Vitro Cell Dev. Biol. 25:1989;659-668.
12. ′ -monophosphate or a cyclic nucleotide phosphodiesterase inhibitor Endocrinology. 107:1980;626-632.
13. Bonaventure J., Kadhom N., Cohen-Solal L., Ng K.H., Bourguignon J., Lasselin C., Freisinger P. Re-expression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp. Cell. Res. 212. 1994;97-104.
14. Srivastava V.M., Malemud C.J., Sokoloff L. Chondroid expression of lapine articular chondrocytes in spinner culture following monolayer growth. Connect. Tissue Res. 2:1974;127-136.
15. von der Mark K., Gauss V., von der Mark H., Muller P. Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature. 267:1977;531-532.
16. Watt F.M., Dudhia J. Prolonged expression of differentiated phenotype by chondrocytes cultured at low density on a composite substrate of collagen and agarose that restricts cell spreading. Differentiation. 38:1988;140-147.
17. Watt F.M. Effect of seeding density on stability of the differentiated phenotype of pig articular chondrocytes in culture. J. Cell Sci. 89:1988;373-378.
18. Elima K., Vuorio E. Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett. 258:1989;195-198.
19. Miller R.P., Hussain M., Lohin S. Long acting cAMP analogues enhance sulfate incorporation into matrix proteoglycans and suppress cell division of rat chondrocytes in monolayer cultures. J. Cell Physiol. 100:1979;63-76.
20. Takigawa M., Takano T., Suzuki F. Effects of parathyroid hormone and cyclic AMP analogues on the activity of ornithine decarboxylase and expression of the differentiated phenotype of chondrocytes in culture. J. Cell Physiol. 106:1981;259-268.
21. Buhlmann N., Leuthauser K., Muff R., Fischer J.A., Born W. A receptor activity modifying protein (RAMP) 2-dependent adrenomedullin receptor is a calcitonin gene related peptide receptor when coexpressed with human RAMP 1. Endocrinology. 140:1999;2883-2890.
22. Kuwasako K., Shimekake Y., Masuda M., Nakahara K., Yoshida T., Kitaura M., Kitamura K., Eto T., Sakata T. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. 275:2000;29602-29609.
23. Kuwasako K., Kitamura K., Ito K., Uemura T., Yanagita Y., Kato J., Sakata T., Eto T. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors. J. Biol. Chem. 276:2001;49459-49465.
24. Matsuo H., Miyata A., Mizuno K. Novel C-terminally amidated opioid peptide in human phaeochromocytoma tumor. Nature. 305:1983;721-723.
25. Kitamura K., Tanaka T., Kato J., Eto T., Tanaka K. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem. Biophys. Res. Commun. 161:1989;348-352.
26. Yamamoto O., Hamada T., Tokui N., Sasaguri Y. Comparison of three in vitro assay systems used for assessing cytotoxic effect of heavy metals on cultured human keratinocytes. J. UOEH. 23:2001;35-44.
27. Galfre G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 73:1981;3-46.
28. Ohta H., Tsuji T., Asai S., Sasakura K., Teraoka H., Kitamura K., Kangawa K. One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin. Chem. 45:1999;244-251.
29. Hojo Y., Ikeda U., Ohya K., Ichida M., Kario K., Takahashi M., Ikeda M., Minota S., Isumi Y., Minamino N., Ishimitsu T., Shimada K. Interaction between monocytes and vascular endothelial cells induces adrenomedullin production. Atherosclerosis. 155:2001;381-387.
30. Uemura T., Kato J., Kuwasako K., Kitamura K., Kagawa K., Eto T. Aldosterone augments adrenomedullin production without stimulating pro-adrenomedullin N-terminal 20 peptide secretion in vascular smooth muscle cells. J. Hypertens. 20:2002;1209-1214.
31. Horio T., Kohno M., Kano H., Ikeda M., Yasunari K., Yokokawa K., Minami M., Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ. Res. 77:1995;660-664.
32. Miller M.J., Martinez A., Unsworth E.J., Thiele C.J., Moody T.W., Elsasser T., Cuttitta F. Adrenomedullin expression in human tumor cell lines. It's potential role as an autocrine growth factor. J. Biol. Chem. 271:1996;23345-23351.
33. Moody T.W., Miller M.J., Martinez A., Unsworth E., Cuttitta F. Adrenomedullin binds with high affinity, elevates cyclic AMP, and stimulates c-fos mRNA in C6 glioma cells. Peptides. 18:1997;1111-1115.
34. Segawa K., Minami K., Sata T., Kuroiwa A., Shigematsu A. Inhibitory effect of adrenomedullin on rat mesangial cell mitogenesis. Nephron. 74:1996;577-579.
35. Shimekake Y., Nagata K., Ohta S., Kambayashi Y., Teraoka H., Kitamura K., Eto T., Kangawa K., Matsuo H. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J. Biol. Chem. 270:1995;4412-4417.
36. Kloth S., Ebenbeck C., Kubitza M., Schmidbauer A., Rockl W., Minnuth W. Stimulation of renal microvascular development under organotypic culture conditions. FASEB. 9:1995;963-967.
37. Dharmavaram R.M., Liu G., Tuan R.S., Stokes D.G., Jimenez S.A. Stable transfection of human fetal chondrocytes with a type 2 procollagen minigene. Arth. Rheum. 42:1999;1433-1442.
38. Stokes D.G., Liu G., Dharmavaram R., Hawkins D., Piera-velazquez S., Jimenez S.A. Regulation of type 2 collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem. J. 360:2001;461-470.
39. Anette S., Inger J.O. Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries. Neurosci. Lett. 258:1998;41-44.
40. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.